Furthermore, more comprehensive studies should also include simultaneous intravitreal and serum EPO concentration measurements, in order to obtain a more precise role of EPO in different stages of ischemic diseases, including diabetes mellitus, in order to find new possibilities for a better quality treatment and a better quality of life for patients with diabetic retinopathy. The gene discussed is EPO; the disease is ischemic disease.